-
BPMC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Blueprint Medicines (BPMC)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 100.86 mm | 100.86 mm | 100.86 mm | 100.86 mm | 100.86 mm | 100.86 mm |
Cash burn (monthly) | (no burn) | (no burn) | 18.67 mm | 10.62 mm | 4.55 mm | 20.18 mm |
Cash used (since last report) | n/a | n/a | 75.09 mm | 42.71 mm | 18.28 mm | 81.17 mm |
Cash remaining | n/a | n/a | 25.77 mm | 58.14 mm | 82.58 mm | 19.69 mm |
Runway (months of cash) | n/a | n/a | 1.4 | 5.5 | 18.2 | 1.0 |
13F holders | Current |
---|---|
Total holders | 316 |
Opened positions | 53 |
Closed positions | 42 |
Increased positions | 138 |
Reduced positions | 81 |
13F shares | Current |
---|---|
Total value | 5.26 tn |
Total shares | 64.63 mm |
Total puts | 1.18 mm |
Total calls | 2.25 mm |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 7.12 mm | $658.51 bn |
Vanguard | 6.68 mm | $618.22 bn |
T. Rowe Price | 5.39 mm | $498.32 mm |
FMR | 4.52 mm | $417.80 bn |
Wellington Management | 3.96 mm | $366.73 bn |
STT State Street | 2.77 mm | $255.83 bn |
William Blair Investment Management | 1.67 mm | $154.92 bn |
Geode Capital Management | 1.48 mm | $136.94 bn |
MQBKY Macquarie Group Limited | 1.26 mm | $116.89 bn |
JPM JPMorgan Chase & Co. | 1.22 mm | $113.04 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Jan 25 | Jeffrey W. Albers | Common Stock | Sell | Dispose S | No | Yes | 110.61 | 200 | 22.12 k | 152,396 |
21 Jan 25 | Jeffrey W. Albers | Common Stock | Sell | Dispose S | No | Yes | 109.92 | 7,400 | 813.41 k | 152,596 |
21 Jan 25 | Jeffrey W. Albers | Common Stock | Sell | Dispose S | No | Yes | 109.11 | 7,561 | 824.98 k | 159,996 |
21 Jan 25 | Jeffrey W. Albers | Common Stock | Option exercise | Acquire M | No | Yes | 36.05 | 10,000 | 360.50 k | 167,557 |
21 Jan 25 | Jeffrey W. Albers | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 36.05 | 10,000 | 360.50 k | 105,000 |
21 Jan 25 | Christina Rossi | Common Stock | Sell | Dispose S | No | Yes | 111.81 | 121 | 13.53 k | 67,109 |
21 Jan 25 | Christina Rossi | Common Stock | Sell | Dispose S | No | Yes | 110.78 | 808 | 89.51 k | 67,230 |
21 Jan 25 | Christina Rossi | Common Stock | Sell | Dispose S | No | Yes | 110 | 816 | 89.76 k | 68,038 |
21 Jan 25 | Christina Rossi | Common Stock | Sell | Dispose S | No | Yes | 108.99 | 529 | 57.66 k | 68,854 |
21 Jan 25 | Kate Haviland | Common Stock | Sell | Dispose S | No | Yes | 110.24 | 1,446 | 159.41 k | 149,378 |